Abstract
We sought to assess temporal trends in peripheral artery disease (PAD)-related hospitalization
rates in Ontario. Trends in quarterly rates of PAD hospitalization per 100,000 Ontarians
between 2006 and 2019 were assessed using autocorrelated linear regression. Stratified
analyses according to age, sex, and most responsible diagnosis code type (with vs
without diabetes-specific PAD codes) were performed. From 2006 to 2019, overall PAD
hospitalizations did not decrease significantly when diabetes-specific codes were
included. A significant decrease was observed among women and those older than 65
years old. Future studies of PAD epidemiology and outcomes using administrative data
should include diabetic angiopathy.
Résumé
Nous avons cherché à évaluer les tendances temporelles des taux d'hospitalisation
liés aux maladies artérielles périphériques (MAP) en Ontario. Les tendances des taux
trimestriels d'hospitalisation liés aux MAP par tranches de 100 000 Ontariens entre
2006 et 2019 ont été évaluées par régression linéaire autocorrélée. Des analyses stratifiées
ont été effectuées en fonction de l’âge, du sexe et du type de code diagnostique le
plus significatif (avec vs sans codes de MAP faisant référence au diabète). De 2006
à 2019, les hospitalisations liées aux MAP n'ont dans l'ensemble pas diminué de façon
notable après l'ajout de codes faisant référence au diabète. Une diminution significative
a été observée chez les femmes et les personnes de plus de 65 ans. Les études ultérieures
sur l’épidémiologie et l'issue des MAP qui seront réalisées à partir de données administratives
devraient inclure l'angiopathie diabétique.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Prevalence and treatment patterns of lower extremity peripheral arterial disease among patients at risk in ambulatory health settings.Can J Cardiol. 2011; 27 (e11-8): 389
- Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis.Lancet Glob Health. 2019; 7: e1020-e1030
- Complex evolution of epidemiology of vascular diseases, including increased disease burden: from 2000 to 2015.Can J Cardiol. 2020; 36: 740-746
- Epidemiology and risk of amputation in patients with diabetes mellitus and peripheral artery disease.Arterioscler Thromb Vasc Biol. 2020; 40: 1808-1817
- Recent temporal changes in atherosclerotic cardiovascular diseases in Ontario: clinical and health systems impact.Can J Cardiol. 2017; 33: 378-384
- International Statistical Classification of Diseases and Related Health Problems. Tenth Revision, Canada. Canadian Institute for Health Information, 2015
ICD 10 Version: 2016. International Statistical Classification of Diseases and Related Health Problems 10th Revision. Available at: https://icd.who.int/browse10/2016/en. Accessed November 23, 2020.
SAS. SAS/ETSreg; 13.2 User's Guide. The AUTOREG Procedure. Available at: https://support.sas.com/documentation/onlinedoc/ets/132/autoreg.pdf. Accessed May 14, 2021.
- A new look at the statistical model identification.IEEE Trans Automat Contr. 1974; 19: 716-723
- Recent trends in hospitalizations for cardiovascular disease, stroke, and vascular cognitive impairment in Canada.Can J Cardiol. 2020; 36: 1081-1090
- Time trends in peripheral artery disease incidence, prevalence and secondary preventive therapy: a cohort study in The Health Improvement Network in the UK.BMJ Open. 2018; 8e018184
- Peripheral angioplasty with same-day discharge in patients with intermittent claudication.J Vasc Surg. 2006; 44: 115-118
- Evolving trends in the epidemiology, risk factors, and prevention of type 2 diabetes: a review.Can J Cardiol. 2018; 34: 552-564
- Type 2 diabetes in adolescents and young adults.Lancet Diabetes Endocrinol. 2018; 6: 69-80
- Peripheral arterial disease in people with diabetes.Diabetes Care. 2003; 26: 3333-3341
- Global vascular guidelines on the management of chronic limb-threatening ischemia.J Vasc Surg. 2019; 69 (e40): 3S-125S
- Population-based secular trends in lower-extremity amputation for diabetes and peripheral artery disease.CMAJ. 2019; 191: E955-E961
- Trends in incidence of total or type 2 diabetes: systematic review.BMJ. 2019; 366: l5003
- Sex differences in cardiovascular medication prescription in primary care: a systematic review and meta-analysis.JAMA. 2020; 9e014742
- Statin adherence: does gender matter?.Curr Atheroscler Rep. 2016; 18: 63
- Adherence to medication according to sex and age in the CHARM programme.Eur J Heart Fail. 2009; 11: 1092-1098
- Medication non-adherence and poor glycaemic control in patients with type 2 diabetes mellitus.Diabetes Res Clin Pract. 2012; 97: 377-384
- Validation of diagnosis and procedure codes for revascularization for peripheral artery disease in Ontario administrative databases.Clin Invest Med. 2021; 44: E36-E43
Article info
Publication history
Published online: July 14, 2021
Accepted:
July 7,
2021
Received:
May 25,
2021
Footnotes
See editorial by Hackam, pages 1496–1497 of this issue.
See page 1511 for disclosure information.
Identification
Copyright
© 2021 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- The Peripheral Arterial Disease Pandemic: No Let-up in SightCanadian Journal of CardiologyVol. 37Issue 10
- PreviewIn a recent systematic review it was estimated that the global prevalence of peripheral artery disease (PAD) was 5.6%, with higher prevalence estimates in high-income countries than in low-income countries.1 Worldwide, a total of 237 million people aged 25 years and older were living with PAD in 2015.1 Patients with PAD are at elevated risk of major adverse limb events and major adverse cardiovascular events.2 Extensive evidence suggests that patients with PAD are undertreated with respect to vasculoprotective medications and lifestyle modification.
- Full-Text
- Preview
